Grifols, S.A. (GRFS): Price and Financial Metrics


Grifols, S.A. (GRFS): $7.95

-0.10 (-1.24%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

GRFS POWR Grades

  • Value is the dimension where GRFS ranks best; there it ranks ahead of 85.83% of US stocks.
  • The strongest trend for GRFS is in Growth, which has been heading down over the past 177 days.
  • GRFS ranks lowest in Quality; there it ranks in the 5th percentile.

GRFS Stock Summary

  • For GRFS, its debt to operating expenses ratio is greater than that reported by 87.72% of US equities we're observing.
  • With a year-over-year growth in debt of 49.5%, GRIFOLS SA's debt growth rate surpasses 80.13% of about US stocks.
  • GRIFOLS SA's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -36.98%, greater than the shareholder yield of merely 13.6% of stocks in our set.
  • Stocks that are quantitatively similar to GRFS, based on their financial statements, market capitalization, and price volatility, are KTCC, STVN, NTCO, AVGR, and EBIX.
  • Visit GRFS's SEC page to see the company's official filings. To visit the company's web site, go to www.grifols.com.

GRFS Stock Price Chart Interactive Chart >

Price chart for GRFS

GRFS Price/Volume Stats

Current price $7.95 52-week high $13.34
Prev. close $8.05 52-week low $5.71
Day low $7.89 Volume 528,555
Day high $8.23 Avg. volume 1,072,128
50-day MA $6.98 Dividend yield N/A
200-day MA $9.72 Market Cap 5.47B

Grifols, S.A. (GRFS) Company Bio


Grifols, S.A. (Catalan: [ˈɡɾifuls]) is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma-based products, a field in which it is the European leader and largest worldwide, the company also supplies devices, instruments, and reagents for clinical testing laboratories. (Source:Wikipedia)


GRFS Latest News Stream


Event/Time News Detail
Loading, please wait...

GRFS Latest Social Stream


Loading social stream, please wait...

View Full GRFS Social Stream

Latest GRFS News From Around the Web

Below are the latest news stories about GRIFOLS SA that investors may wish to consider to help them evaluate GRFS as an investment opportunity.

Grifols S.A. (NASDAQ:GRFS) Is Now 30.11% Above Its 52-Week Low. How Long Will It Continue To Rise?

In last trading session, Grifols S.A. (NASDAQ:GRFS) saw 0.55 million shares changing hands with its beta currently measuring 0.43. Company’s recent per share price level of $8.17 trading at -$0.06 or -0.73% at ring of the bell on the day assigns it a market valuation of $6.82B. That closing price of GRFS’s stock is at … Grifols S.A. (NASDAQ:GRFS) Is Now 30.11% Above Its 52-Week Low. How Long Will It Continue To Rise? Read More »

Marketing Sentinel | November 26, 2022

Grifols Needs To Deleverage (NASDAQ:GRFS)

The company reached an 8.6x net debt/EBITDA ratio. Despite the high leverage, 65% of its debt is fixed. Click here to read our latest analysis of GRFS stock.

Seeking Alpha | November 18, 2022

Introducing Our Rant Against Grifols S.A.

Grifols S.A. (GRFS)’s stock is trading at $7.93 at the moment marking a rise of 8.81% from the last session close. As of this writing, shares are priced at -40.54% less than their 52-week high of $13.34, and 38.91% over their 52-week low of $5.71. Based on the past 30-day period, the stock price is […]

US Post News | November 11, 2022

Grifols S.A. reports Q3 results

Grifols S.A. press release (GRFS): Q3 Revenue of €4.35B.Net profit of €188 millionReported EBITDA totals EUR 927 million

Seeking Alpha | November 10, 2022

Spanish pharmaceuticals firm Grifols reports 30% drop in nine-month profit

Spanish pharmaceutical company Grifols reported a 30% drop in nine-month net profit on Tuesday, due in part to acquisition costs.

Reuters | November 8, 2022

Read More 'GRFS' Stories Here

GRFS Price Returns

1-mo 13.73%
3-mo -2.81%
6-mo -33.36%
1-year -26.80%
3-year -64.34%
5-year -61.04%
YTD -29.21%
2021 -37.78%
2020 -20.15%
2019 28.71%
2018 -17.77%
2017 44.48%

Continue Researching GRFS

Here are a few links from around the web to help you further your research on Grifols SA's stock as an investment opportunity:

Grifols SA (GRFS) Stock Price | Nasdaq
Grifols SA (GRFS) Stock Quote, History and News - Yahoo Finance
Grifols SA (GRFS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8315 seconds.